JHMD - ETF AI Analysis
Top Page
John Hancock Multifactor Developed International ETF (JHMD)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year, supported by positive returns over the past three and twelve months.
Broad International Diversification
Holdings spread across many developed markets like Japan, the UK, Germany, and France help reduce the impact of problems in any single country.
Multiple Sectors and Strong Leaders
The fund invests across many sectors and includes strong-performing companies such as ASML and several large financial and healthcare names, which can support overall returns.
Negative Factors
Heavy Tilt to Financials
A sizable allocation to financial stocks means the fund could be more sensitive to banking and interest-rate shocks.
Concentrated Country Exposure
Large weights in a few countries, especially Japan and the UK, increase the impact that economic or political issues in those markets can have on the ETF.
Moderate Expense Ratio
The fund’s fees are not especially low for a passive international ETF, which slightly reduces the net return investors keep over time.
JHMD vs. SPDR S&P 500 ETF (SPY)
AUM942.53M
RegionDeveloped Markets
Expense Ratio0.39%
Beta0.71
IssuerJohn Hancock
Inception DateDec 15, 2016
Dividend Yield3.04%
Asset ClassEquity
Index TrackedJohn Hancock Dimensional Developed International Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume77,419
30 Day Avg. Volume103,843
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
50.70Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering571
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
JHMD Summary
JHMD, the John Hancock Multifactor Developed International ETF, tracks the John Hancock Dimensional Developed International Index and invests in a wide mix of companies from developed countries outside the U.S., such as Japan, the UK, and Germany. It holds well-known names like ASML and Novartis, and spreads money across many sectors, including financials, industrials, and health care. Investors might consider JHMD to diversify beyond the U.S. and seek long-term growth from overseas markets. A key risk is that international stocks can be volatile and move up or down with global markets and currency changes.
How much will it cost me?The John Hancock Multifactor Developed International ETF (JHMD) has an expense ratio of 0.39%, which means you’ll pay $3.90 per year for every $1,000 invested. This cost is slightly higher than average for passively managed ETFs because it uses a multifactor strategy to optimize risk and reward across developed international markets.
What would affect this ETF?Positive drivers for JHMD include potential economic growth in developed international markets outside North America, which could boost the performance of its top holdings like Vinci SA and Novartis AG. However, negative factors such as rising interest rates or economic slowdowns in Europe could impact sectors like Financials and Industrials, which make up a significant portion of the ETF's exposure.
JHMD Top 10 Holdings
JHMD leans heavily on Europe and other developed markets outside North America, with a mix of financials, industrials, energy, and health care setting the tone. ASML has been a key engine for longer-term gains, even if its recent momentum looks a bit mixed. Big banks like HSBC and BBVA are rising and help anchor performance, while Vinci has been lagging and acts more like a brake than a booster. Defensive names such as Novartis and Roche are steady contributors, and BP’s improving share price adds some extra fuel to the fund.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.11% | $19.97M | €597.04B | 127.48% | 76 Outperform | |
| Vinci SA | 1.56% | $14.71M | €66.62B | -4.04% | 76 Outperform | |
| Banco Bilbao Vizcaya Argentaria | 1.15% | $10.89M | €127.26B | 73.12% | 76 Outperform | |
| HSBC Holdings | 1.14% | $10.79M | £266.83B | 61.62% | 80 Outperform | |
| Engie SA | 1.04% | $9.83M | €70.61B | 38.26% | 64 Neutral | |
| BASF SE | 0.99% | $9.37M | €43.35B | 7.04% | 61 Neutral | |
| Bayer | 0.93% | $8.80M | €45.25B | 60.39% | 54 Neutral | |
| Novartis AG | 0.90% | $8.46M | CHF231.67B | 37.69% | 80 Outperform | |
| Roche Holding AG | 0.80% | $7.56M | $345.58B | 34.54% | 73 Outperform | |
| Mitsubishi UFJ Financial Group | 0.77% | $7.24M | ¥41.98T | 52.62% | 76 Outperform |
JHMD Technical Analysis
Positive
―
Price Trends
44.31
Positive
43.53
Positive
42.29
Positive
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JHMD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 44.62, equal to the 50-day MA of 44.31, and equal to the 200-day MA of 42.29, indicating a bullish trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JHMD.
JHMD Peer Comparison
Comparison Results
Performance Comparison
JHMD
John Hancock Multifactor Developed International ETF
44.82
7.71
20.78%
DMXF
iShares ESG Advanced MSCI EAFE ETF
―
―
―
IQDG
WisdomTree International Quality Dividend Growth Fund
―
―
―
NUDM
Nuveen ESG International Developed Markets Equity ETF
―
―
―
DWM
WisdomTree International Equity Fund
―
―
―
EFAX
SPDR MSCI EAFE Fossil Fuel Free ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents